📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Selective silencing of a-globin by the histone demethylase inhibitor IOX1: a potentially new pathway for treatment of ß-thalassemia. (2017)

First Author: Mettananda S

Attributed to: Developing an initiative in stem cell editing for human genetic diseases. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3324/haematol.2016.155655

PubMed Identifier: 27810991

Publication URI: http://europepmc.org/abstract/MED/27810991

Type: Journal Article/Review

Volume: 102

Parent Publication: Haematologica

Issue: 3

ISSN: 0390-6078